1.08
전일 마감가:
$1.08
열려 있는:
$1.09
하루 거래량:
19,484
Relative Volume:
0.81
시가총액:
$12.50M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-2.0377
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
+0.00%
1개월 성능:
-7.68%
6개월 성능:
+48.92%
1년 성능:
-36.84%
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TXMD
Therapeuticsmd Inc
|
1.08 | 12.50M | 996.00K | -6.09M | -9.76M | -0.53 |
![]()
ZTS
Zoetis Inc
|
147.46 | 64.82B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.12 | 47.56B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.28 | 43.31B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.68 | 21.67B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
397.97 | 18.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2019-12-02 | 개시 | Guggenheim | Buy |
2019-10-17 | 개시 | H.C. Wainwright | Buy |
2019-04-30 | 재개 | Noble Capital Markets | Outperform |
2018-06-15 | 개시 | JP Morgan | Overweight |
2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2016-11-22 | 재개 | Jefferies | Buy |
2016-11-22 | 개시 | Oppenheimer | Outperform |
2016-11-07 | 재개 | Guggenheim | Buy |
2016-04-04 | 개시 | Goldman | Buy |
2015-12-08 | 재확인 | Jefferies | Buy |
2015-12-08 | 재확인 | Stifel | Buy |
2015-09-21 | 재확인 | Jefferies | Buy |
2015-06-09 | 개시 | Guggenheim | Buy |
2014-07-08 | 개시 | FBR Capital | Outperform |
2014-04-17 | 재확인 | Noble Financial | Buy |
2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
Retail Trends: Is TherapeuticsMD Inc stock a falling knife or bargain buyJuly 2025 Snapshot & Capital Efficiency Focused Ideas - خودرو بانک
Growth Recap: What are analysts price targets for TherapeuticsMD IncWeekly Trend Summary & Long-Term Capital Growth Strategies - خودرو بانک
Can TherapeuticsMD Inc. rally from current levels2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Will TherapeuticsMD Inc. benefit from macro trendsStock Surge & Long-Term Safe Investment Plans - newser.com
Published on: 2025-09-15 16:30:10 - خودرو بانک
Will a bounce in TherapeuticsMD Inc. offer an exit2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
What earnings revisions data tells us about TherapeuticsMD Inc.Weekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Real time breakdown of TherapeuticsMD Inc. stock performance2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
TherapeuticsMD Inc. stock trendline breakdown2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Is TherapeuticsMD Inc. still worth holding after the dipRate Cut & Verified Momentum Stock Ideas - newser.com
Price momentum metrics for TherapeuticsMD Inc. explainedJuly 2025 Setups & High Accuracy Investment Signals - newser.com
Smart tools for monitoring TherapeuticsMD Inc.’s price actionGap Down & Precise Buy Zone Tips - newser.com
How to recover losses in TherapeuticsMD Inc. stockJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Live market analysis of TherapeuticsMD Inc.Insider Selling & Free Expert Verified Stock Movement Alerts - Newser
Is TherapeuticsMD Inc. stock poised for growthTrade Analysis Summary & Community Verified Swing Trade Signals - Newser
TherapeuticsMD Inc. stock momentum explainedQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Momentum divergence signals in TherapeuticsMD Inc. chartChart Signals & High Conviction Buy Zone Picks - Newser
What machine learning models say about TherapeuticsMD Inc.Market Risk Summary & Daily Entry Point Trade Alerts - Newser
Will TherapeuticsMD Inc. stock recover after recent dropQuarterly Risk Review & AI Optimized Trading Strategy Guides - Newser
TherapeuticsMD Inc. stock trend forecast2025 Earnings Surprises & Long-Term Investment Growth Plans - Newser
What indicators show strength in TherapeuticsMD Inc.Buy Signal & Community Verified Trade Alerts - Newser
Relative strength of TherapeuticsMD Inc. in sector analysisJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
Will breakout in TherapeuticsMD Inc. lead to full recoveryRisk Management & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-11 23:46:09 - Newser
What technical models suggest about TherapeuticsMD Inc.’s comebackMarket Growth Summary & Expert Curated Trade Ideas - Newser
How to escape a deep drawdown in TherapeuticsMD Inc.Trend Reversal & Free Safe Capital Growth Stock Tips - Newser
Visual analytics tools that track TherapeuticsMD Inc. performance2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Using portfolio simulators with TherapeuticsMD Inc. includedEarnings Recap Report & AI Driven Stock Reports - Newser
Risk vs reward if holding onto TherapeuticsMD Inc.July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
Applying big data sentiment scoring on TherapeuticsMD Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Therapeuticsmd Inc 주식 (TXMD) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
자본화:
|
볼륨(24시간):